Immunotherapy

Cancer immunotherapy (sometimes called immuno-oncology) is the stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease.

Read more in the app

Study: suppressing key protein may unlock immunotherapy for Glioblastoma - EurekAlert

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer - EurekAlert

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

New hope for immunotherapy as prostate cancer treatment

Study reveals hope for immunotherapy as prostate cancer treatment - EurekAlert

Why brain cancer is often resistant to immunotherapy

Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder cancer

Computer model helps identify cancer-fighting immune cells key to immunotherapy

New combination immunotherapy for melanoma and breast cancer

Immunotherapy against cancer: How therapeutic antibodies do their job - EurekAlert

Immunotherapy against cancer: How therapeutic antibodies do their job

Researchers shed light on how to predict which skin cancer patients are most likely to respond to immunotherapy

Unlocking the potential to better target cancer with immunotherapy

AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer - EurekAlert

Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer - EurekAlert

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer - EurekAlert

Immunotherapy boosts survival of advanced Hodgkin lymphoma

92% Survival Rate: Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma

Immune signatures may predict adverse events from immunotherapy

Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy